Compound,CAS,MW,MW_Reference,Intake_rate,Intake_rate_Reference,Fub,Fub_Reference,Clint,Clint_Reference,pKa_Acceptor,pKa_Acceptor_Reference,pKa_Donor,pKa_Donor_Reference,logKow,logKow_Reference,Neutral_Form,Neutral_Form_Reference,Plasma_Conc_0,Plasma_Conc_10,Plasma_Conc_50,Plasma_Conc_90,logKlipw,logDlipw,IC10_Baseline,AC10,AC10_Top,AC10_HillSlope,EC50,Endpoint_effect,IC10,IC10_Top,IC10_HillSlope,IC50,Endpoint_cytotox,SR,TR
"1,1-Dimethylpiperidinium chloride",24307-26-4,149.66,U.S. EPA CompTox Dashboard,8.51e-09,Wambaugh 2014,0.65,OPERA (0.47),0,OPERA (0.64),None,Sipes 2017,None,Sipes 2017,-2.34,ACD/Labs Consensus logP,0,ACD/Labs GALAS,0,1.3e-08,2.2e-08,3.4e-08,-2.2434,-3.2434,10.485228141476,0.160657629323436,100,1.52026932685494,0.788337536155088,NVS_LGIC_rNNR_BungSens,10.485228141476,100,1,11.4394706509153,Baseline,21113999753.692,1
Didodecyldimethylammonium bromide,3282-73-3,462.645,U.S. EPA CompTox Dashboard,3.24e-07,Wambaugh 2014,0.03,OPERA (0.69),15.62,OPERA (0.61),None,Sipes 2017,None,Sipes 2017,4.24,ACD/Labs Consensus logP,0,ACD/Labs GALAS,0,1e-09,3e-09,1e-08,4.4024,3.4024,2.02655030684166,1.01507128946124,98.7945617266092,3.19439063533087,1.35774236950276,ATG_XTT_Cytotoxicity_up|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_CASP3_HEPG2_viability|TOX21_ESRE_BLA_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_NFkB_BLA_agonist_viability|TOX21_RAR_LUC_Agonist_viability|TOX21_RAR_LUC_Antagonist_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_SBE_BLA_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_p53_BLA_p2_viability|TOX21_p53_BLA_p5_viability,1.01507128946124,98.7945617266092,3.19439063533087,1.35774236950276,ATG_XTT_Cytotoxicity_up|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_CASP3_HEPG2_viability|TOX21_ESRE_BLA_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_NFkB_BLA_agonist_viability|TOX21_RAR_LUC_Agonist_viability|TOX21_RAR_LUC_Antagonist_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_SBE_BLA_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_p53_BLA_p2_viability|TOX21_p53_BLA_p5_viability,1,10.2678382216187
Rotenone,83-79-4,41.073,U.S. EPA CompTox Dashboard,2.91e-06,U.S. EPA CompTox Dashboard,0.78,OPERA (0.62),1.66,OPERA (0.54),#NV,ACD/Labs GALAS,#NV,ACD/Labs GALAS,1.69,ACD/Labs Consensus logP,1,ACD/Labs GALAS,0,3.177e-06,7.627e-06,1.774e-05,1.8269,1.8269,3.02931951997304,-1.79899983743032,100,1,-1.54429913274646,APR_HepG2_MitoMembPot_72h_dn|NCCT_MITO_inhib_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn|NVS_GPCR_h5HT6|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX|bursts per minute|percent spikes in network spike|mean correlation|percent spikes in burst|mean firing rate,-1.54667371981945,51.9639967875681,0.799640379006737,-0.360032088884916,APR_HepG2_CellLoss_24h_dn|APR_HepG2_MicrotubuleCSK_1h_dn|NCCT_HEK293T_CellTiterGLO|NCCT_MITO_viability|TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Agonist_viabillity|TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_RAR_LUC_Agonist_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_TR_LUC_GH3_Antagonist_viability|cell viability,1.78782957637826,37669.7935275903
Tibrofan,15686-72-3,439.95,U.S. EPA CompTox Dashboard,2.88e-07,Wambaugh 2014,0.03,OPERA (0.69),15.35,OPERA (0.62),None,Sipes 2017,10.99,Sipes 2017,4.72,ACD/Labs Consensus logP,1,ACD/Labs GALAS,0,1e-09,2e-09,6e-09,4.8872,4.8872,1.36837592316275,0.364493027966035,100,1.88724614009895,0.870119977818634,TOX21_MMP_fitc,0.656644538637074,100,1.35720725739305,1.35973723449567,TOX21_TR_LUC_GH3_Antagonist_viability,1.95952816744528,5.14910069050765
Coumaphos,56-72-4,362.76,U.S. EPA CompTox Dashboard,1.17e-07,Wambaugh 2014,0.291000097,Wambaugh 2019,30.5,Wambaugh 2019,None,Sipes 2017,None,Sipes 2017,3.86,ACD/Labs Consensus logP,1,ACD/Labs GALAS,0,0,1e-09,3e-09,4.0186,4.0186,1.72520073477528,-0.108854386439325,100,1,0.845388123,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX|TOX21_MMP_ratio_down,0.300627095225656,69.6100347679586,1.15494359773573,1.21388122458826,TOX21_MMP_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability,2.56732873476668,26.5811422472587
